CT结肠成像在梗阻性结直肠癌患者同步结肠病变诊断中的效能
本研究评估CT结肠成像(CTC)在因梗阻性结直肠癌致结肠镜检查不完整患者中诊断同步结肠病变的准确性。70例纳入分析,27例(39%)存在至少一个6 mm及以上同步病变,4例(6%)共5个同步结直肠癌。CTC对6 mm及以上同步病变的每例敏感度0.93、特异度0.98,对同步进展性肿瘤每例敏感度0.94。
要点
- 梗阻性结直肠癌致结肠镜检查不完整时,CTC对6 mm及以上同步病变每例敏感度0.93、特异度0.98。
- 同步进展性肿瘤患病率高(23%),CTC对同步结直肠癌每例敏感度1.00(4/4)。
- CTC对6 mm及以上同步病变每病灶敏感度0.88(37/42),进展性肿瘤每病灶敏感度0.92(22/24)。
核心结论
- CTC是检测梗阻性结直肠癌患者同步结肠病变的高准确性检查方法,进展性肿瘤患病率高(23%)。
研究设计与样本
- 本研究为评估CTC诊断准确性的研究,纳入109例因结直肠癌致结肠镜检查不完整并接受CTC检查的患者,其中70例有参考标准(手术报告、首次监测结肠镜)者纳入分析;CTC采用静脉对比增强,检查前进行导泻、粪便标记和结肠扩张。
诊断标准与关键数值
- 以手术报告和首次监测结肠镜为参考标准,CTC诊断6 mm及以上同步结肠病变的每例敏感度0.93(25/27)、特异度0.98(42/43)、阳性预测值0.96、阴性预测值0.95。
- CTC诊断同步结直肠癌的每例敏感度1.00(4/4);诊断同步进展性肿瘤(进展性腺瘤和结直肠癌)的每例敏感度0.94(15/16)。
- CTC检测6 mm及以上同步病变的每病灶敏感度0.88(37/42);全部腺瘤性病变每病灶敏感度0.89(55/62);进展性肿瘤每病灶敏感度0.92(22/24)。
- 70例患者中27例(39%)存在至少一个6 mm及以上同步病变,4例(6%)共有5个同步结直肠癌;59个病变中直径10 mm及以上20个、6-9 mm 30个、5 mm及以下9个。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this study was to evaluate the accuracy of CT colonography (CTC) in the diagnosis of synchronous colonic lesions in a cohort of patients with an occlusive colorectal cancer (CRC) causing incomplete colonoscopy. SUBJECTS AND METHODS. Among 109 patients with CRC causing incomplete colonoscopy who underwent CTC with IV contrast enhancement after cathartic purgation, fecal tagging, and colon distention, 70 (mean age, 70 years) for whom reference standards (surgical reports, first surveillance colonoscopy) were available were evaluated. Per-patient and per-lesion sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) of CTC in the diagnosis of synchronous colonic lesions measuring 6 mm or larger were assessed. RESULTS. Twenty-seven of the 70 patients (39%) had at least one 6-mm or larger synchronous lesion, and four patients (6%) had a total of five synchronous CRCs. Per-patient sensitivity in diagnosing synchronous CRC was 1.00 (4/4). There were 59 lesions: 20 with a diameter of 10 mm or greater; 30, 6-9 mm; and nine, 5 mm or less. The overall per-patient CTC sensitivity in detecting synchronous lesions 6 mm or larger was 0.93 (25/27); specificity, 0.98 (42/43); PPV, 0.96; and NPV, 0.95. Per-patient sensitivity for the diagnosis of synchronous advanced neoplasia (advanced adenoma and colorectal cancers) was 0.94 (15/16). Per-lesion CTC sensitivity for detecting synchronous lesions 6 mm or larger was 0.88 (37/42); all adenomatous lesions, 0.89 (55/62); and advanced neoplasia, 0.92 (22/24). CONCLUSION. CTC is a highly accurate test for detecting synchronous colonic lesions in patients with occlusive CRC. The prevalence of advanced neoplasia is high (23%).
引用
- Flor N, Ceretti AP, Luigiano C, et al. Performance of CT Colonography in Diagnosis of Synchronous Colonic Lesions in Patients With Occlusive Colorectal Cancer. AJR Am J Roentgenol. 2019. PMID: 31670584. doi:10.2214/AJR.19.21810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。